Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip To Host Fourth Quarter and Full-Year 2016 Results Call
DENVER , Feb. 15, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its fourth quarter and full-year 2016 financial results on Friday, March 3, 2017 , before the opening of the U.S. financial markets. Daniel E.
Toggle Summary BioScrip, Inc. Joins Coalition to Advocate for Vulnerable Medicare Patients Losing Access to Home Infusion Care
Calls on Congress to Fix Unintended Consequence of 21 st Century Cures Act; Encourages Patients, Families, Others to Join Outreach DENVER --(BUSINESS WIRE)--Feb. 6, 2017-- BioScrip, Inc. (NASDAQ:BIOS), a leading national provider of infusion and home care management solutions, announced today it
Toggle Summary BioScrip Announces Amendment to Credit Agreement and New Senior Loan Facility
DENVER , Jan. 06, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has entered into an agreement to amend its existing Credit Agreement (the “Amendment”), dated
Toggle Summary BioScrip Provides Business Update and Outlines Plan to Increase Liquidity
Provides Update on Fourth Quarter 2016 and Comments on Business Impact of 21st Century Cures Act DENVER , Dec. 14, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it
Toggle Summary BioScrip Reports Third Quarter 2016 Financial Results
Q3 Consolidated Revenue of $224.5 Million, Loss from continuing operations, net of income taxes of $(11.1) Million and Adjusted EBITDA of $3.5 Million DENVER , Nov. 07, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced financial results for the
Toggle Summary BioScrip To Host 2016 Third Quarter Results Call
DENVER , Oct. 17, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2016 third quarter financial results on Monday, November 7, 2016 , after the close of the U.S. financial markets. Daniel E. Greenleaf , President and Chief Executive Officer,
Toggle Summary BioScrip Completes Acquisition of Home Solutions
DENVER , Sept. 09, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that it has completed the acquisition of HS Infusion Holdings, Inc.
Toggle Summary BioScrip and Home Solutions Enter Into Amended Asset Purchase Agreement to Expedite Closing
DENVER and HAMMONTON, N.J. , Sept. 02, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions and HS Infusion Holdings, Inc. ("Home Solutions"), today announced that they have further amended
Toggle Summary BioScrip Enters into a Tax Asset Protection Plan to Protect its Valuable Tax Assets
DENVER , Aug. 12, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) (“BioScrip” or the “Company”) today announced that its Board of Directors has adopted a Tax Asset Protection Plan designed to protect the Company’s ability to utilize its net operating loss carryforwards (NOLs), which total
Toggle Summary BioScrip Reports Second Quarter 2016 Financial Results
Q2 Consolidated Revenue of $232.5 Million , Loss from continuing operations, net of income taxes of $(8.3) Million and Adjusted EBITDA of $10.4 Million Full Year 2016 Guidance Updated to Reflect Pending Acquisition of Home Solutions DENVER , Aug. 08, 2016 (GLOBE NEWSWIRE) -- BioScrip, Inc.